Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | Director | February 28, 2018 | March 07, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date February 28, 2018 · Filed March 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,168 |
Ending reported balance
After 2018-02-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-02-28 · Exercise / conversion · Acquired 5,452 · Balance 21,323 F1: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Row 2 · 2018-02-28 · Disposition to issuer · Disposed 3,155 · Balance 18,168 F1: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $53.29 · Expires 2018-05-18 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-28 · Exercise / conversion · Disposed 5,452 · Balance 0 F1: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2018 Filed Mar 7, 2018 00:55 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 5,452 | $0.00 Strike: $53.29 | $0.00 |
DisclosureSEC source: 0001209191-18-017544 · doc4.xml · derivative · entry 3 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,452 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 7, 2018 00:55 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 3,155 | $92.10 | $290,575.50 |
DisclosureSEC source: 0001209191-18-017544 · doc4.xml · nonDerivative · entry 2 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,168 F1 · kind: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 7, 2018 00:55 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 5,452 | $53.29 | $290,537.08 |
DisclosureSEC source: 0001209191-18-017544 · doc4.xml · nonDerivative · entry 1 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:28 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031104 · doc4.xml · nonDerivative · entry 1 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,871 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:31 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 13,064 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-016815 · doc4.xml · derivative · entry 3 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,064 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:31 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 5,287 | $56.69 | $299,720.03 |
DisclosureSEC source: 0001209191-17-016815 · doc4.xml · nonDerivative · entry 2 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,206 F1 · kind: The reporting person received 7,777 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,287 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on March 1, 2017 of $56.69. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 22:31 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 13,064 | $22.94 | $299,688.16 |
DisclosureSEC source: 0001209191-17-016815 · doc4.xml · nonDerivative · entry 1 Cardoso Pedro · CIK 0001463406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.